[HTML][HTML] Triple therapy versus dual bronchodilation and inhaled corticosteroids/long-acting β-agonists in COPD: accumulating evidence from network meta-analyses
M Cazzola, L Calzetta, P Rogliani, MG Matera - Pulmonary Therapy, 2019 - Springer
Guidelines are mainly based on evidence of well-designed randomized controlled trials
(RCTs), but there are limitations to the transferability of conclusions of RCTs to usual care …
(RCTs), but there are limitations to the transferability of conclusions of RCTs to usual care …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - European Respiratory …, 2018 - Eur Respiratory Soc
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
Triple therapy trials in COPD: a precision medicine opportunity
S Suissa, A Ariel - European Respiratory Journal, 2018 - Eur Respiratory Soc
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document for the
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …
Triple therapy versus dual or monotherapy with long-acting bronchodilators for chronic obstructive pulmonary disease. A systematic review and meta-analysis
Rationale: There is uncertainty on the use of using triple therapy (inhaled
corticosteroids/long-acting β-agonist/long-acting muscarinic antagonist) inhaler therapy for …
corticosteroids/long-acting β-agonist/long-acting muscarinic antagonist) inhaler therapy for …
Comparative effectiveness and safety of triple therapy and non-triple therapy interventions for COPD: an overview of systematic reviews
S Zhang, J Wang, X Li, H Zhang - Therapeutic Advances in …, 2024 - journals.sagepub.com
Background: Some systematic reviews (SRs) on triple therapy (consisting of long-acting β2-
agonist, long-acting muscarinic antagonist, and inhaled corticosteroid, LABA/LAMA/ICS) for …
agonist, long-acting muscarinic antagonist, and inhaled corticosteroid, LABA/LAMA/ICS) for …
Triple versus dual inhaler therapy in moderate‐to‐severe COPD: A systematic review and meta‐analysis of randomized controlled trials
Introduction Treatment of chronic obstructive pulmonary disease (COPD) is evolving
specially with triple inhaler therapy. Objectives To perform a meta‐analysis to ascertain the …
specially with triple inhaler therapy. Objectives To perform a meta‐analysis to ascertain the …
Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
Y Zheng, J Zhu, Y Liu, W Lai, C Lin, K Qiu, J Wu, W Yao - Bmj, 2018 - bmj.com
Objective To compare the rate of moderate to severe exacerbations between triple therapy
and dual therapy or monotherapy in patients with chronic obstructive pulmonary disease …
and dual therapy or monotherapy in patients with chronic obstructive pulmonary disease …
Dual–Versus Mono–Bronchodilator Therapy in Moderate to Severe COPD: A Meta-analysis
M Lipari, PB Kale-Pradhan… - Annals of …, 2020 - journals.sagepub.com
Background: Chronic obstructive pulmonary disease (COPD) guidelines recommend both
long-acting and dual bronchodilator therapy. It is unclear if there are differences in efficacy …
long-acting and dual bronchodilator therapy. It is unclear if there are differences in efficacy …
Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta …
Background Long‐acting bronchodilators such as long‐acting β‐agonist (LABA), long‐
acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations …
acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations …
The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a …
CC Lai, CH Chen, CYH Lin, CY Wang… - International journal of …, 2019 - Taylor & Francis
Background This study aims to compare the effects of single inhaler triple therapy comprised
of inhaled corticosteroids (ICSs), long-acting β2-agonists (LABAs), and long-acting …
of inhaled corticosteroids (ICSs), long-acting β2-agonists (LABAs), and long-acting …
相关搜索
- meta analysis bronchodilator therapy
- β agonists dual bronchodilation
- accumulating evidence dual bronchodilation
- β agonists accumulating evidence
- severe copd bronchodilator therapy
- acting bronchodilators combination therapy
- severe copd meta analysis
- meta analysis corticosteroid doses
- bayesian network corticosteroid doses
- meta analysis bayesian network
- meta analysis combination therapy
- meta analysis acting bronchodilators